Navigation Links
Rigel to Host Update Conference Call
Date:10/31/2008

SOUTH SAN FRANCISCO, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that members of Rigel's senior management team will host a conference call with simultaneous webcast to provide a company update on November 3, 2008 at 5:30 a.m. PST/8:30 a.m. EST.

Conference Call and Webcast Information

To access the live call, please dial 800-265-0241 (domestic) or 617-847-8704 (international) 10 minutes prior to the start time and use the passcode 39911675. A replay of the call will be available, in podcast format, at approximately 9:30 a.m. EST on November 3, 2008 until November 10, 2008. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international) and use the passcode 37653591. The conference call will also be webcast live and can be accessed from Rigel's website at http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheum
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Rigel to Present at BIO Investor Forum 2007
2. Rigel to Present Research Programs at Scientific Conferences
3. Rigel Announces Pricing of Public Offering of Common Stock
4. Rigel to Present at BIO CEO & Investor Conference
5. Rigel Announces Fourth Quarter and Year End 2007 Financial Results
6. CardioDynamics Provides 2007 Shareholder Meeting Update
7. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
8. GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
9. SemBioSys updates Apo AI development program
10. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
11. Biopure Gives Update on Malaysia Joint Venture Discussions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/ -- Biotech firm Replikins Ltd., which has anal...ndemic through the prediction, outbreak, and progr... latest biochemical analysis of the virus. The new... Flu") virus has dropped from its peak of 3.7 (s.d...spring of 2009 to resting non-epidemic levels this...
(Date:11/25/2009)...Newswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a l...ed today that it executed,a joint venture (JV) agr...ology Co., Ltd. (Sinovac Dalian). The JV will rese... vaccines. Sinovac will contribute its expertise,a...rld-class vaccines; the,other party will bring its...
(Date:11/24/2009)...e-FirstCall/ -- IES (Nasdaq: IESC ), a leading na...ystems and services for the commercial, industrial... commercial business group has been awarded a cont...rical systems for the Level 4 bio-safety lab (BSL-...esearch Institute of Infectious Diseases (USAMRIID...
(Date:11/24/2009)...Nov. 24 Dow AgroSciences... of Hyland Seeds, a division of Thompsons Limited ... will further expand Dow AgroSciences, current see...ction of SmartStax(TM) in 2010 and Dow AgroS...n in 2012. The transactional close is expected in ...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
... Revenue of $88 to $90 Million and Net Income of $... HARBIN, China, Sept. 25 /Xinhua-PRNewswire-FirstC...e Medical" or "the Company") (Nasdaq: CSKI ), a,l...ducing over-the-counter,drugs in the People,s Repu... increased its revenue and earnings guidance for t...
...Sept. 25 Bion Environmental Technologies,Inc. (OT...n was received,today that its patent application e...ystem" has been granted by the Commonwealth of Aus...umber of 2002227224. The,official filing date is a...,in force until an expiration date of November 8, ...
... N.J., Sept. 25 Osteotech, Inc.,(Nasdaq: OSTE ),...ons for,regenerative medicine, announced today the...its Board of Directors. Dr. Laurencin joined the,B... will serve on both the,Audit and the Compensation.... Fallon, III, Chairman of the Board of Directors,...
Other Biology Technology:China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income 2China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income 3Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment 2Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors 2
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlif...ort revealing that the last remaining population o...y due to the rising tide of poaching and habitat l... inform Russian officials of what needs to be done...iggest cat. , The report was releas...
(Date:11/24/2009)..., Md. (November 24, 2009) New research on bacteri...cosystems reveals predictable temporal patterns, s...ies as markers for monitoring climate change in th... the Proceedings of the National Academy of Scien...es in the six rivers shifted synchronously over ti...
(Date:11/23/2009)...n, D.C. The community-associated strain of the de...sistant to most common antibioticsposes a far grea...ing its way into hospitals, according to a study i...ses . , The new threat is easily picked up in f...nd has increased the overall burden of MRSA within...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New study finds MRSA on the rise in hospital outpatients 2Genes May Link Hip Fractures and Heart Disease 59850 1Genes May Link Hip Fractures and Heart Disease 59850 2Genes May Link Hip Fractures and Heart Disease 59850 3Experimental treatments restore partial vision to blind people 10444 1Experimental treatments restore partial vision to blind people 10444 2Genomes of 2 popular research strains of E coli sequenced 10441 1Genomes of 2 popular research strains of E coli sequenced 10441 2Genomes of 2 popular research strains of E coli sequenced 10441 3
... , Biologists at the University of California, San...e morning and evening components of the daily biol...ed in the March 13 issue of Science , solves a lo... mechanisms that control plant clocks and could pr...f agricultural crops. , The finding is the first ...
... Philadelphia (March 18, 2009) As any parent kno...esearch from the University of Washington and the ...g for sweetness has a biological basis and is rela...onship between sweet preference and growth makes i...ic demands increase. Children are programmed to l...
... Being satisfied with one,s appearance is one of ...lf image. However, in today,s appearance culture i...ren and young people are dissatisfied with their a...ect to bullying are particularly critical of their...long period. This is revealed in a new thesis in p...
Other Biology News:Missing piece of plant clock found 2Liking sweets makes sense for kids 2Children who are dissatisfied with their appearance often have problems with their peer group 2
...d 36kDa (C) subunits Formulation: 10% glycerol, 20...l, 1mM MgCl2, 1mM EGTA, 0.1mM MnCl2 1mM DTT, and 0... vitro dephosphorylation of proteins. Purification...filtration chromatography Quality Assurance: routi...
...acellular Localization Kit provides a straight for... of your design, in an efficient yet non-destructi...ellular localization and functional inhibition of ...introduction of the labeled siRNA into mammalian c...
...acellular Localization Kit with TransIT-siQUEST Tr...roach to directly label and deliver siRNA, of your...r, for in vitro tracking experiments. Subcellular ...ene expression can be monitored following introduc...
...eproducible immunoprecipitation (IP) by using a 96...e than regular IPs, which are problematic with reg...srupting the agarose bed. The binding of the antib...ible, and elution of the immune complex can occur ...
Biology Products: